NA
Venditti, A., Kicinski, M., Audisio, E., Luppi, M., Lunghi, M., Foà, R., et al. (2025). MRD Assessment in Patients With Acute Myeloid Leukemia Aged ≥ 60 Years Treated With a 10‐Day Decitabine Schedule Versus Intensive Chemotherapy in the AML21 Study. AMERICAN JOURNAL OF HEMATOLOGY, 1, 1-5 [10.1002/ajh.27763].
MRD Assessment in Patients With Acute Myeloid Leukemia Aged ≥ 60 Years Treated With a 10‐Day Decitabine Schedule Versus Intensive Chemotherapy in the AML21 Study
Francesco, LanzaMembro del Collaboration Group
;
2025
Abstract
NAFile in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


